ArticleBreast cancer (Tokyo, Japan)2022

Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study.

Su-Jin Koh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.